Variantyx Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 192

Employees
  • Latest Deal Type

  • Debt

  • Latest Deal Amount

  • $20M

  • Investors

  • 9

Variantyx General Information

Description

Developer of a whole-genome sequencing platform intended to diagnose and generate clinical reports for rare inherited disorders. The company's platform simplifies sample collection, DNA extraction and sequencing, data analysis, interpretation and clinical reporting by automating them, enabling hospital and commercial labs to profitably expand their test menu with validated genomic diagnostic solutions.

Contact Information

Website
www.variantyx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Primary Office
  • 1671 Worcester Road
  • Suite 300
  • Framingham, MA 01701
  • United States
+1 (617) 000-0000

Variantyx Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Variantyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 18-Oct-2022 $20M 0000 Completed Generating Revenue
5. Later Stage VC (Series C2) 14-Feb-2022 000.00 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 15-Nov-2021 0000 000.00 0000 Completed Generating Revenue
3. Debt - PPP 02-May-2020 00000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jan-2019 $7M $11.8M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) $4.8M $4.8M 000.00 Completed Startup
To view Variantyx’s complete valuation and funding history, request access »

Variantyx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series C-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 6,206,645 $0.010000 $1.37 $1.37 1x $1.37 11.69%
Series A 3,709,246 $0.010000 $1.31 $1.31 1x $1.31 6.99%
To view Variantyx’s complete cap table history, request access »

Variantyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a whole-genome sequencing platform intended to diagnose and generate clinical reports for rare inherited di
Biotechnology
Framingham, MA
192 As of 2023
0000
000000000 0000

000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inc
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000000000000
Cherry Hill, NJ
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Variantyx Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personalis Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000 000 Formerly VC-backed Cherry Hill, NJ 00 000.00 000000000 000.00
0000000 Formerly VC-backed South Plainfield, NJ 000 000000&0
000000 0000 Venture Capital-Backed Chicago, IL 0000 00.000 00000000000 00.000
00000000 00000000 Formerly VC-backed San Jose, CA 000 00000 000000&0 00000
You’re viewing 5 of 12 competitors. Get the full list »

Variantyx Executive Team (10)

Name Title Board Seat Contact Info
Haim Neerman Co-Founder, Chief Executive Officer & Board Member
Yaron Rachmany Chief Operating Officer
Thomas DeLuca Chief Human Resources Officer
Eric Olivares Ph.D Chief Scientific Officer
Tomer Jackman Co-Founder & Vice President of Customer Support & Laboratory Services
You’re viewing 5 of 10 executive team members. Get the full list »

Variantyx Board Members (7)

Name Representing Role Since
David Margulies MD Self Board Member 000 0000
Gideon Argov Self Board Member 000 0000
Guy Ezekiel MD Self Chairman of the BOD 000 0000
Haim Neerman Variantyx Co-Founder, Chief Executive Officer & Board Member 000 0000
Hillel Bachrach Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Variantyx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Variantyx Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Peregrine Ventures Venture Capital Minority 000 0000 000000 0
20/20 HealthCare Partners Family Office Minority 000 0000 000000 0
GHS Investment Management (Canada) Company Corporation Minority 000 0000 000000 0
IBM Ventures Corporate Venture Capital Minority 000 0000 000000 0
Peregrine Systems Corporation Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial